HilleVax Inc. (HLVX)
HilleVax Statistics
Share Statistics
HilleVax has 50.14M shares outstanding. The number of shares has increased by 0.17% in one year.
| Shares Outstanding | 50.14M |
| Shares Change (YoY) | 0.17% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 86.75% |
| Shares Floating | 22.76M |
| Failed to Deliver (FTD) Shares | 284 |
| FTD / Avg. Volume | 0.15% |
Short Selling Information
The latest short interest is 1.54M, so 3.1% of the outstanding shares have been sold short.
| Short Interest | 1.54M |
| Short % of Shares Out | 3.1% |
| Short % of Float | 6.98% |
| Short Ratio (days to cover) | 4.62 |
Valuation Ratios
The PE ratio is -0.69 and the forward PE ratio is -1.07. HilleVax's PEG ratio is 0.53.
| PE Ratio | -0.69 |
| Forward PE | -1.07 |
| PS Ratio | 0 |
| Forward PS | 0.6 |
| PB Ratio | 0.66 |
| P/FCF Ratio | -0.93 |
| PEG Ratio | 0.53 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for HilleVax.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.84, with a Debt / Equity ratio of 0.16.
| Current Ratio | 10.84 |
| Quick Ratio | 10.84 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | -0.16 |
| Debt / FCF | -0.22 |
| Interest Coverage | 46.8 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-10.52M |
| Employee Count | 14 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -89.48% in the last 52 weeks. The beta is 0.86, so HilleVax's price volatility has been higher than the market average.
| Beta | 0.86 |
| 52-Week Price Change | -89.48% |
| 50-Day Moving Average | 1.74 |
| 200-Day Moving Average | 2.3 |
| Relative Strength Index (RSI) | 44.68 |
| Average Volume (20 Days) | 189.76K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -155.29M |
| Net Income | -147.27M |
| EBITDA | -155.29M |
| EBIT | -150.59M |
| Earnings Per Share (EPS) | -3 |
Balance Sheet
The company has 154.47M in cash and 24.51M in debt, giving a net cash position of 129.95M.
| Cash & Cash Equivalents | 154.47M |
| Total Debt | 24.51M |
| Net Cash | 129.95M |
| Retained Earnings | -535.83M |
| Total Assets | 192.69M |
| Working Capital | 161.89M |
Cash Flow
In the last 12 months, operating cash flow was -108.79M and capital expenditures -522K, giving a free cash flow of -109.31M.
| Operating Cash Flow | -108.79M |
| Capital Expenditures | -522K |
| Free Cash Flow | -109.31M |
| FCF Per Share | -2.22 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HLVX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for HLVX is $2, which is 27.4% higher than the current price. The consensus rating is "Hold".
| Price Target | $2 |
| Price Target Difference | 27.4% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
Scores
| Altman Z-Score | -4.21 |
| Piotroski F-Score | 3 |